Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Telmisartan on Early Markers of Atherosclerosis in Hypertension With and Without Hyperlipidemia
2006-004853-38Phase 4Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan in hypertension (HTN), hyperlipidemia and atherosclerosis, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Expression and activity of RAS-regulated molecules involved in early atherosclerosis. Started May 2007; status: terminated.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)hyperlipidemiaatherosclerosis
Beyond the preview
Go deeper on 2006-004853-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004853-38.